To examine the effects of blocking tumor-derived CSF-1 on TMEM doorway activity, we stained the tumor tissue for endomucin and TMR-Dextran and measured the amounts of extravascular dextran compared to the vascular area (Fig. 5A). This evidence concerns the gene CSF1 and neoplasm.